Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB08914> ?p ?o ?g. }
Showing items 1 to 17 of
17
with 100 items per page.
- drugbank:DB08914 type drugbank_vocabulary:Drug assertion.
- drugbank:DB08914 label "Insulin, isophane [drugbank:DB08914]" assertion.
- drugbank:DB08914 seeAlso novolin-n-innolet-drug.htm assertion.
- drugbank:DB08914 seeAlso insulin-isophane.html assertion.
- drugbank:DB08914 seeAlso DB08914 assertion.
- drugbank:DB08914 description "Isophane insulin or NPH insulin (neutral protamine Hagedorn) is an intermediate-acting insulin to improve glycemic control. It is synthesized using a strain of Escherichia coli bacteria that has been genetically altered to produce human insulin. Human insulin isophane suspension consists of a crystalline suspension of human insulin with protamine and zinc. This combination results in an intermediate-acting insulin with a slower onset of action and longer duration of activity than regular human insulin." assertion.
- drugbank:DB08914 identifier "drugbank:DB08914" assertion.
- drugbank:DB08914 title "Insulin, isophane" assertion.
- drugbank:DB08914 drugbank_vocabulary:x-cas cas:53027-39-7 assertion.
- drugbank:DB08914 drugbank_vocabulary:drugbank-id "DB08914" assertion.
- drugbank:DB08914 bio2rdf_vocabulary:x-identifiers.org DB08914 assertion.
- drugbank:DB08914 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB08914" assertion.
- drugbank:DB08914 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB08914 bio2rdf_vocabulary:identifier "DB08914" assertion.
- drugbank:DB08914 drugbank_vocabulary:x-wikipedia wikipedia:NPH_insulin assertion.
- drugbank:DB08914 drugbank_vocabulary:x-kegg kegg:D04547 assertion.
- drugbank:DB08914 drugbank_vocabulary:x-ndc ndc:0002-8315-01 assertion.